The Latest Breaking News from HIV

Decisions from the U.S. Preventative Services Task Force impact millions of people’s access to preventative care for cancer, infectious diseases and mental health

In June, the U.S. Food and Drug Administration (FDA) approved Gilead Sciences, Inc.'s (NASDAQ:GILD) Yeztugo (lenacapavir) as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV in adults and adolescents weighing at least 35kg, making it the first and only twice-yearly option available in the U.S. for people who need or…

The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV

The drug is expected to be formally approved by the European Commission this year.

My phone wouldn’t stop ringing – nurses, social workers, young mothers – all begging for help. ‘I’ve lost my job,’ ‘I have no food,’ ‘What do we do now?’ I felt helpless.

The US Senate votes to keep money for the President’s Emergency Plan for Aids Relief from a package of more than $9 billion in cuts going through Congress

The move to save PEPFAR funding may prove useful in rallying GOP support from powerful lawmakers like Senate Appropriations chair Susan Collins, an outspoken critic of Trump’s proposed cuts.

The United States has deported five immigrants from Vietnam, Jamaica, Cuba, Yemen and Laos to Eswatini, a small country in southern Africa where the king still holds absolute power

The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government says it has saved the lives of over 25 million people around the world with HIV

The week brought a mix of stories that stirred the pot in various sectors. From Bill Gates’ warning about the devastating effects of USAID funding cuts on HIV programs in Africa, to the first June budget surplus since 2017 under Donald Trump’s administration, the news cycle was anything but dull.…

South Africa has played a historic, global role in scientific research, from COVID-19 vaccines to HIV